GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

ALM201   Click here for help

GtoPdb Ligand ID: 11485

Compound class: Peptide
Comment: ALM201 is a small 23 amino acid peptide that is derived from the FK506 binding protein FKBPL. It has anti-angiogenic and anti-tumour activities [2].
No information available.
Summary of Clinical Use Click here for help
ALM201 has completed Phase 1a clinical evaluation, and was granted FDA orphan drug designation for ovarian cancer in 2017 [1].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03427073 A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours Phase 1 Interventional Almac Discovery